Knowles/$KN
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Knowles
Knowles Corp is engaged in the manufacturing of micro-acoustic microphones and balanced armature speakers, audio solutions, high-performance capacitors, and radio frequency filtering products. It operates in two segments; the Precision Devices segment specializes in the design and delivery of high-performance capacitor products and RF solutions; and Medtech & Specialty Audio segment designs and manufactures microphones and balanced armature speakers used in applications. The majority of its revenue comes from the Precision Devices. Geographically, it operates in United States, Asia, Other Americas, Europe and Others, out of which United States generates maximum revenue.
- Ticker
- $KN
- Sector
- Digital Hardware
- Primary listing
- NYSE
- Employees
- 5,200
- Headquarters
- Itasca, United States
- Website
- www.knowles.com
Knowles Metrics
BasicAdvanced
$2.8B
40.39
$0.82
1.59
-
Price and volume
Market cap
$2.8B
Beta
1.59
52-week high
$42.93
52-week low
$20.57
Average daily volume
777K
Financial strength
Current ratio
2.937
Quick ratio
1.504
Long term debt to equity
0.163
Total debt to equity
0.168
Interest coverage (TTM)
9.84%
Profitability
EBITDA (TTM)
139.4
Gross margin (TTM)
45.02%
Net profit margin (TTM)
10.76%
Operating margin (TTM)
15.27%
Effective tax rate (TTM)
16.04%
Revenue per employee (TTM)
$130,000
Management effectiveness
Return on assets (TTM)
5.88%
Return on equity (TTM)
9.86%
Valuation
Price to earnings (TTM)
40.392
Price to revenue (TTM)
4.232
Price to book
4.12
Price to tangible book (TTM)
7.01
Price to free cash flow (TTM)
35.504
Free cash flow yield (TTM)
2.82%
Free cash flow per share (TTM)
0.929
Growth
Revenue change (TTM)
16.15%
Earnings per share change (TTM)
71.62%
3-year revenue growth (CAGR)
8.98%
10-year revenue growth (CAGR)
-2.32%
3-year earnings per share growth (CAGR)
-25.90%
10-year earnings per share growth (CAGR)
-11.61%
What the Analysts think about Knowles
Analyst ratings (Buy, Hold, Sell) for Knowles stock.
Analyst projections of the future price of Knowles stock.
Bulls say / Bears say
Knowles raised its full-year 2026 revenue outlook to about $689 million, up 16% year on year, after third-quarter revenue grew 20% and beat the top of guidance. This points to strong near-term trading momentum. (Knowles)
Precision Devices grew revenue 33% in the third quarter, with orders near $180 million and a book-to-bill ratio of 1.5. Orders span medtech, defence, industrial and electrification, and include a $15 million defence RF-filter order. (Knowles, The Motley Fool)
The company generated $45 million of operating cash in the third quarter and ended it with net leverage of just 0.4 times. That gives Knowles room to fund capacity expansion while also reducing debt and returning capital to shareholders. (Knowles)
Despite higher sales, third-quarter gross margin fell to 44.2% from 45.7% a year earlier. Knowles cited higher factory costs, an unfavourable product mix and production-transfer costs, alongside inventory adjustments. (U.S. Securities and Exchange Commission)
Precision Devices is close to capacity, so management expects sequential growth to be roughly flat in the first half of 2027 before new capacity is fully available in the second half. Planned 2027 capital spending will also rise to 5%–7% of revenue from the usual 3%–5%. (The Motley Fool, Knowles)
MedTech & Specialty Audio grew only 4% in the third quarter, and some hearing-health demand was pulled forward by earlier product launches. Management also expects the stamping-business exit to create a 2%–3% revenue headwind in 2027. (U.S. Securities and Exchange Commission, The Motley Fool)
Data summarised monthly by Lightyear AI. Last updated on 5 Nov 2026.
Knowles Financial Performance
Revenues and expenses
Knowles Earnings Performance
Company profitability
Upcoming events
No upcoming events
Knowles News
AllArticlesVideos
Funds containing Knowles
Fund name | Fund size | $KN weighting |
|---|---|---|
iShares S&P SmallCap 600$IDP6 | $2.5B | 0.16% |
iShares S&P Small Cap 600£ISP6 | $2.5B | 0.16% |
SPDR Russell 2000 US Small Cap€R2US | $4.7B | 0.10% |
SPDR Russell 2000 US Small Cap£R2SC | $4.7B | 0.10% |
iShares MSCI USA Small Cap ESG Enhanced CTB€SXRG | $2.7B | 0.06% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.


